Alliancebernstein L.P. Zai Lab LTD Transaction History

Alliancebernstein L.P.

$278 Billion
Q2 2024

A detailed history of Alliancebernstein L.P. transactions in Zai Lab LTD stock. As of the latest transaction made, Alliancebernstein L.P. holds 183,507 shares of ZLAB stock, worth $4.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

183,507

Previous 144,805 26.73%

Holding current value

$4.43 Million

Previous $2.32 Million 37.13%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $530,991 - $834,028	38,702 Added 26.73%	183,507 $3.18 Million
Q1 2024 May 14, 2024	BUY	$15.95 - $26.8 $1.13 Million - $1.9 Million	70,900 Added 95.93%	144,805 $2.32 Million
Q4 2023 Feb 14, 2024	BUY	$22.97 - $30.58 $1.3 Million - $1.73 Million	56,684 Added 329.16%	73,905 $2.02 Million
Q3 2023 Nov 14, 2023	BUY	$22.72 - $31.49 $90,016 - $124,763	3,962 Added 29.88%	17,221 $418,000
Q2 2023 Aug 15, 2023	BUY	$25.3 - $39.67 $335,452 - $525,984	13,259 New	13,259 $367,000
Q2 2021 Jul 30, 2021	SELL	$125.11 - $180.0 $2.63 Million - $3.78 Million	-20,989 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$126.27 - $191.71 $747,392 - $1.13 Million	5,919 Added 39.28%	20,989 $2.8 Million
Q4 2020 Feb 08, 2021	SELL	$81.94 - $135.34 $974,922 - $1.61 Million	-11,898 Reduced 44.12%	15,070 $2.04 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $147,259 - $179,765	2,009 Added 8.05%	26,968 $2.24 Million
Q2 2020 Aug 13, 2020	SELL	$48.82 - $82.53 $356,678 - $602,964	-7,306 Reduced 22.64%	24,959 $2.05 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $727,846 - $1.17 Million	18,615 Added 136.37%	32,265 $1.66 Million
Q4 2019 Feb 18, 2020	BUY	$29.79 - $43.06 $406,633 - $587,769	13,650 New	13,650 $568,000

Others Institutions Holding ZLAB

# of Institutions

117

Shares Held

40.9M

Call Options Held

63.1K

Put Options Held

420K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.36B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Zai Lab LTD Transaction History